Chlorpromazine's Potential Role in Palliating Distressing Symptoms Associated With Hyperactive Delirium in Patients at End of Life.

Tiefenthaler, Casey M; Hirst, Jeremy M; Edmonds, Kyle P; Atayee, Rabia S

Tiefenthaler, Casey M; Hirst, Jeremy M; Edmonds, Kyle P; Atayee, Rabia S.

Affiliation

Tiefenthaler CM; Department of Pharmacy, University of California Health, La Jolla, California, USA.
Hirst JM; Division of Geriatrics, Gerontology, and Palliative Care, Department of Medicine, UC San Diego Section of Palliative Care, La Jolla, California, USA.
Edmonds KP; Palliative Care Program, University of California San Diego, San Diego, California, USA.
Atayee RS; Division of Geriatrics, Gerontology, and Palliative Care, Department of Medicine, UC San Diego Section of Palliative Care, La Jolla, California, USA.

J Palliat Med ; 26(6): 826-830, 2023 06.

Article in En | MEDLINE | ID: mdl-36847737

Subject(s)

Delirium; Neoplasms; Humans; Chlorpromazine/therapeutic use; Psychomotor Agitation/drug therapy; Psychomotor Agitation/complications; Psychomotor Agitation/prevention & control; Delirium/drug therapy; Neoplasms/complications; Death; Palliative Care

Key words

chlorpromazine; end of life; hyperactive delirium; palliative care; proportionate sedation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Delirium / Neoplasms Type of study: Diagnostic_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Palliat Med Journal subject: SERVICOS DE SAUDE Year: 2023 Document type: Article Affiliation country: United States Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google